Literature DB >> 26086179

An Isoflavone from Leiophyllum buxifolium and Its Antiproliferative Effect.

Dan Tian1, John R Porter1.   

Abstract

A new C-methylisoflavone, isosideroxylin (1), and a known C-methylflavone, sideroxylin (2), were isolated from the EtOAc extract of the leaves of Leiophyllum buxifolium. The two compounds were evaluated with the sulforhodamine B assay for their antiproliferative effects against ER(-) MDA-MB-231 and ER(+) MCF-7 breast cancer cell lines and the NIH3T3 mouse fibroblast cell line. Isosideroxylin (1) displayed a selective antiproliferative effect against MDA-MB-231 cells.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26086179     DOI: 10.1021/acs.jnatprod.5b00100

Source DB:  PubMed          Journal:  J Nat Prod        ISSN: 0163-3864            Impact factor:   4.050


  2 in total

1.  New Isoflavanes from Spatholobus suberectus and Their Cytotoxicity against Human Breast Cancer Cell Lines.

Authors:  Fu Peng; Huan Zhu; Chun-Wang Meng; Yan-Rui Ren; Ou Dai; Liang Xiong
Journal:  Molecules       Date:  2019-09-04       Impact factor: 4.411

2.  Clinical Relevance and Tumor Growth Suppression of Mitochondrial ROS Regulators along NADH:Ubiquinone Oxidoreductase Subunit B3 in Thyroid Cancer.

Authors:  Jiao Zhu; Xiaobo Zheng; Dan Lu; Yun Zheng; Jun Liu
Journal:  Oxid Med Cell Longev       Date:  2022-01-17       Impact factor: 6.543

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.